This activity focuses on the role of wearable devices in the timely identification of atrial fibrillation (AF) and the evolving evidence around the rationale for and efficacy/safety of early rhythm control strategies, including guideline recommendations and expert insights on the use of antiarrhythmic drugs (AADs) and catheter ablation.
CEAtlas helps you evaluate the course and plan the trip. Registration is completed with the accredited provider while direct marketplace licensing is being established.